Clinical Trials Browser

Interventional × surufatinib × Head & Neck × Clear all

Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

NCT05989425 2023-08-14

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Phase 2 Recruiting

32 enrolled

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT04910854 2021-06-02

Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Phase 2 Unknown

27 enrolled

Head & Neck

Head and Neck Cancers - Salivary Gland

NCT04524884 2020-08-24

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Phase 2 Unknown

10 enrolled

Head & Neck

Thyroid Neoplasms

NCT02614495 2020-02-13

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Phase 2 Completed

66 enrolled

Head & Neck

Thyroid Neoplasms

Clinical Trials

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma